+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Probiotic Ingredients Market Size, Share & Trends Analysis Report Analysis By Ingredients (Bacteria, Yeast), By Application, By End Use, By Form, By Region, And Segment Forecasts, 2019 - 2025

  • ID: 4118789
  • Report
  • 150 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Biocodex, Inc.
  • Chr. Hansen Holding A/S
  • Ganeden Inc.
  • Lallemand, Inc.
  • Orbit Biotech Pvt. Ltd.
  • ProbioFerm
  • MORE
The global probiotic ingredients market size is projected to reach USD 3.56 billion by 2025, according to this report. It is expected to expand at a CAGR of 7.9% over the forecast period. Increasing consumer awareness regarding preventive healthcare has emerged as a key market driver. Probiotics play a great role in preventive healthcare as they prevent the occurrence of a disease by strengthening the immune system of the body.

Another significant factor bolstering the product demand across the globe is the increasing investments by key market players in R&D activities with respect to the development of efficient probiotic strains. There have been advancements in the delivery systems used for delivering probiotics in the human body. Efficient strains have been developed that work in compatibility with these delivery systems. This allows a high number of probiotics to reach the body parts such as the intestines, thus increasing their effectiveness.

Companies have developed and identified proprietary strains for specific applications. These strains meet different requirements possessed by different medical conditions. Lactobacillus fermentum VRI-003 PCC and Lactobacillus rhamnosus HN001 are used to cure Eczema. Lactobacillus acidophilus NCFM and Bifidobacterium animalis lactis Bi-07 strains are used to cure cold. Lactobacillus acidophilus, Lactobacillus reuteri RC-14, and Lactobacillus rhamnosus GR-1 are effective for treating vaginal infection.

Europe emerged as the largest probiotic ingredients market in 2018, with a revenue of USD 742.2 million. Rising awareness concerning gut and immune health, prevalence of gut-related diseases, and the presence of geriatric population are some of the key factors contributing significantly to the regional market growth. Increasing consumption of animal probiotic ingredients is anticipated to further fuel the regional expansion. Increasing focus on mortality reduction and growth of animals coupled with the need for feed conversion efficiency is expected to trigger the regional demand.

The market participants have been engaging in mergers and acquisitions in a bid to increase their market share. For instance, in December 2017, Royal DSM, a science-based company headquartered in Netherlands announced the acquisition of Biocare Copenhagen A/S, a Denmark-based food supplements manufacturing and supplying company. The acquisition was intended to expand the former’s product offerings of probiotic gut health ingredients.

Further key findings from the report suggest:
  • In terms of ingredient, bacteria emerged as the largest segment with a revenue of USD 1.74 billion in 2018. The segment is expected to continue its dominance over the forecast period
  • In terms of application, probiotic dietary supplements segment is anticipated to expand at the fastest CAGR of 8.2% over the forecast period, attributable to the increasing demand for these supplements from various industries including pharmaceutical, nutraceutical, and functional supplements
  • In terms of end use, human probiotics segment is expected to lead the market over the forecast period, with animal probiotics segment at a distant second. Advancement in oral probiotic market has contributed to the growth of the human probiotics segment
  • Asia Pacific is anticipated to witness the fastest CAGR of 8.4% over the forecast period. Led by countries such as India, China, and Japan, the Asia Pacific probiotic ingredients market is driven by the increasing adoption of the product predominantly in infant formula
  • The market is highly competitive with a sizable number of domestic and international players sharing the market space. Product innovation and mergers and acquisitions are among the key strategies deployed by prominent players to withstand competition
  • The key market participants are Ganeden, Inc., Probiotical S.p.A., Biocodex, Inc., Sabinsa Corporation, BioGaia AB, Chr. Hansen Holding A/S, and Lallemand, Inc. among others

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Biocodex, Inc.
  • Chr. Hansen Holding A/S
  • Ganeden Inc.
  • Lallemand, Inc.
  • Orbit Biotech Pvt. Ltd.
  • ProbioFerm
  • MORE
Chapter 1 Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased Database
1.1.2 Internal database
1.1.3 Secondary Sources
1.1.4 Third Party Perspective
1.1.5 Primary Research
1.2 Information Analysis & Data Analysis Models
1.3 List to Data Sources

Chapter 2 Executive Summary
2.1 Market Insights
2.2 Segmental Insights
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Value Chain Analysis
3.3.1 Raw Material Trends
3.3.1.1 Major Raw Material Analysis
3.3.1.2 Procurement Best Practices
3.3.2 Manufacturing trends
3.3.2.1 Technology Trends
3.3.2.2 Outsourcing and contract manufacturing trends
3.3.3 cost structure and profit margin analysis
3.3.3.1 Average Selling Price Analysis
3.3.3.2 Profit margin and cost analysis
3.3.4 sales channel analysis
3.3.5 Vendor selection criteria
3.4 Technology Overview
3.4.1 Technology timeline
3.5 Regulatory Framework
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Increasing awareness of consumers toward preventive healthcare
3.6.1.2 Development of efficient probiotic strains
3.6.2 Market restraint Analysis
3.6.2.1 High product development cost and stringent government regulations
3.6.3 Industry challenges
3.7 Business Environment Analysis
3.7.1 Porter’s Analysis
3.7.1.1 Threat of new entrants
3.7.1.2 Bargaining power of suppliers
3.7.1.3 Bargaining power of buyers
3.7.1.4 Threat of substitutes
3.7.1.5 Competitive rivalry
3.7.2 PESTLE Analysis
3.7.2.1 Political Landscape
3.7.2.2 Environmental Landscape
3.7.2.3 Social Landscape
3.7.2.4 Technology Landscape
3.7.2.5 Economic Landscape
3.7.2.6 Legal Landscape
3.7.3 Major Deals & Strategic Alliances Analysis
3.7.3.1 Mergers & AcquIsitions
3.7.3.2 Licensing & partnership
3.8 Market Entry Strategy

Chapter 4 Probiotic ingredients Market: Ingredient Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Probiotic ingredients Market: Ingredient Movement Analysis, 2018 & 2025
4.3 Bacteria
4.3.1 Market estimates & forecasts, 2014 - 2025 (USD Million)
4.3.2 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
4.3.3 Market estimates & forecasts, by region, 2014 - 2025 (USD Million)
4.3.4 Lactobacilli
4.3.4.1 Market estimates & forecasts, in lactobacilli,2014 - 2025 (USD Million)
4.3.4.2 Market estimates & forecasts, in lactobacilli, by application, 2014 - 2025 (USD Million)
4.3.4.3 Market estimates & forecasts, in lactobacilli, by region, 2014 - 2025 (USD Million)
4.3.5 Bifidobacterium
4.3.5.1 Market estimates & forecasts, in bifidobacterium,2014 - 2025 (USD Million)
4.3.5.2 Market estimates & forecasts, in bifidobacterium, by application, 2014 - 2025 (USD Million)
4.3.5.3 Market estimates & forecasts, in bifidobacterium, by region, 2014 - 2025 (USD Million)
4.3.6 Streptococcus
4.3.6.1 Market estimates & forecasts, in streptococcus,2014 - 2025 (USD Million)
4.3.6.2 Market estimates & forecasts, in streptococcus, by application, 2014 - 2025 (USD Million)
4.3.6.3 Market estimates & forecasts, in streptococcus, by region, 2014 - 2025 (USD Million)
4.3.7 Other genus
4.3.6.1 Market estimates & forecasts, in other genus,2014 - 2025 (USD Million)
4.3.6.2 Market estimates & forecasts, in other genus, by application, 2014 - 2025 (USD Million)
4.3.6.3 Market estimates & forecasts, in other genus, by region, 2014 - 2025 (USD Million)
4.4 Yeast
4.4.1 Market estimates & forecasts, 2014 - 2025 (USD Million)
4.4.2 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
4.4.3 Market estimates & forecasts, by region, 2014 - 2025 (USD Million)
4.5 Spore formers
4.5.1 Market estimates & forecasts, 2014 - 2025 (USD Million)
4.5.2 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
4.5.3 Market estimates & forecasts, by region, 2014 - 2025 (USD Million)

Chapter 5 Probiotic Ingredients Market: Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Probiotic Ingredients Market: Application Movement Analysis, 2018 & 2025
5.3 Probiotic food & beverages
5.3.1 Market estimates & forecasts, in probiotic food & beverages, 2014 - 2025 (USD Million)
5.3.2 Market estimates & forecasts, in probiotic food & beverages, by region, 2014 - 2025 (USD Million)
5.4 Probiotic dietary supplements
5.4.1 Market estimates & forecasts, in Probiotic dietary supplements, 2014 - 2025 (USD Million)
5.4.2 Market estimates & forecasts, in Probiotic dietary supplements, by region, 2014 - 2025 (USD Million)
5.5 Animal feed probiotic
5.5.1 Market estimates & forecasts, in Animal feed probiotic, 2014 - 2025 (USD Million)
5.5.2 Market estimates & forecasts, in Animal feed probiotic, by region, 2014 - 2025 (USD Million)

Chapter 6 Probiotic Ingredients Market: End Use Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Probiotic Ingredients Market: End Use Movement Analysis, 2018 & 2025
6.3 Human probiotics
6.3.1 Market estimates & forecasts, for human probiotic, 2014 - 2025 (USD Million)
6.3.2 Market estimates & forecasts, for human probiotic, by region, 2014 - 2025 (USD Million)
6.4 Animal probiotics
6.4.1 Market estimates & forecasts, for animal probiotic, 2014 - 2025 (USD Million)
6.4.2 Market estimates & forecasts, for animal probiotic, by region, 2014 - 2025 (USD Million)

Chapter 7 Probiotic Ingredients Market: Form Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Probiotic Ingredients Market: Form Movement Analysis, 2018 & 2025
7.3 Dry form
7.3.1 Market estimates & forecasts, in dry form, 2014 - 2025 (USD Million)
7.3.2 Market estimates & forecasts, in dry form, by region, 2014 - 2025 (USD Million)
7.4 Liquid form
7.4.1 Market estimates & forecasts, in liquid form, 2014 - 2025 (USD Million)
7.4.2 Market estimates & forecasts, in liquid form, by region, 2014 - 2025 (USD Million)

Chapter 8 Probiotic ingredients Market: Regional Estimates & Trend Analysis
8.1 Definition & Scope
8.2 Probiotic Ingredients Market: Regional movement analysis, 2018 & 2025
8.3 North America
8.3.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.3.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.3.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.3.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.3.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.3.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.3.6 U.S.
8.3.6.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.3.6.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.3.6.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.3.6.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.3.6.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.3.6.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.3.7 Canada
8.3.7.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.3.7.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.3.7.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.3.7.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.3.7.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.3.7.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.3.8 Mexico
8.3.8.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.3.8.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.3.8.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.3.8.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.3.8.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.3.8.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.4 Europe
8.4.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.4.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.4.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.4.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.4.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.4.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.4.6 U.K.
8.4.6.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.4.6.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.4.6.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.4.6.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.4.6.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.4.6.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.4.7 Germany
8.4.7.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.4.7.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.4.7.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.4.7.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.4.7.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.4.7.5 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.4.8 France
8.4.8.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.4.8.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.4.8.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.4.8.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.4.8.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.4.8.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.5 Asia Pacific
8.5.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.5.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.5.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.5.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.5.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.5.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.5.6 India
8.5.6.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.5.6.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.5.6.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.5.6.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.5.6.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.5.6.5 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.5.7 China
8.5.7.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.5.7.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.5.7.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.5.7.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.5.7.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.5.7.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.5.8 Japan
8.5.8.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.5.8.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.5.8.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.5.8.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.5.8.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.5.8.5 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.6 Central & South America
8.6.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.6.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.6.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.6.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.6.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.6.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.6.6 Brazil
8.6.6.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.6.6.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.6.6.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.6.6.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.6.6.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.6.6.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)
8.7 Middle East & Africa
8.7.1 Market estimates & forecasts, 2014 - 2025 (USD million)
8.7.2 Market estimates & forecasts, by ingredient, 2014 - 2025 (USD Million)
8.7.2.1 Market estimates & forecast, by genus, 2014 - 2025 (USD Million)
8.7.3 Market estimates & forecasts, by application, 2014 - 2025 (USD Million)
8.7.4 Market estimates & forecasts, by end use, 2014 - 2025 (USD Million)
8.7.5 Market estimates & forecasts, by form, 2014 - 2025 (USD Million)

Chapter 9 Competitive Analysis
9.1 Key Players’ Recent Developments & Their Impact
9.2 Key Innovators, Market Leader, and Emerging Players
9.3 Vendor Landscape
9.3.1 List of key distributors & channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Company market position analysis
9.4.2 Company ranking
9.4.3 Competitive dashboard analysis
9.4.4 Market differentiators
9.4.5 Synergy Analysis: Major Deals & Strategic Alliances
9.4.6 SWOT Analysis of Public companies
9.5 Private Companies
9.5.1 List of key emerging companies/technology disruptors/innovators
9.5.2 Geographical Presence
9.5.3 Company market position analysis

Chapter 10 Company Profiles
10.1 Probiotical S.p.A.
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 Ganeden Inc.
10.2.1 company Overview
10.2.2 Financial Performance
10.2.2 Product Benchmarking
10.2.4 Strategic Initiatives
10.3 Sabinsa Corporation
10.3.1 company Overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiatives
10.4 Biocodex, Inc.
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiatives
10.5 BioGaia AB
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 Chr. Hansen Holding A/S
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 Strategic Initiatives
10.7 Danisco A/S
10.7.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 Strategic Initiatives
10.8 Danone, Inc.
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Product Benchmarking
10.8.4 Strategic Initiatives
10.9 Lallemand, Inc.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiatives
10.10 Nebraska Cultures
10.10.1 Company Overview
10.10.2 Financial Performance
10.10.3 Product Benchmarking
10.10.4 Strategic Initiatives
10.11 Probi AB
10.11.1 Company Overview
10.11.2 Financial Performance
10.11.3 Product Benchmarking
10.11.4 Strategic Initiatives
10.12 Allianz Biosciences Pvt. Ltd.
10.12.1 Company Overview
10.12.2 Financial Performance
10.12.3 Product Benchmarking
10.12.4 Strategic Initiatives
10.13 Lactosan GmbH & Co. KG
10.13.1 Company Overview
10.13.2 Financial Performance
10.13.3 Product Benchmarking
10.13.4 Strategic Initiatives
10.14 Nutraceutix
10.14.1 Company Overview
10.14.2 Financial Performance
10.14.3 Product Benchmarking
10.14.4 Strategic Initiatives
10.15 Probium LLC
10.15.1 Company Overview
10.15.2 Financial Performance
10.15.3 Product Benchmarking
10.15.4 Strategic Initiatives
10.16 THT s.a.
10.16.1 Company Overview
10.16.2 Financial Performance
10.16.3 Product Benchmarking
10.16.4 Strategic Initiatives
10.17 Vitakem Nutraceutical, Inc.
10.17.1 Company Overview
10.17.2 Financial Performance
10.17.3 Product Benchmarking
10.17.4 Strategic Initiatives
10.18 ProbioFerm
10.18.1 Company Overview
10.18.2 Financial Performance
10.18.3 Product Benchmarking
10.18.4 Strategic Initiatives
10.19 Orbit Biotech Pvt. Ltd.
10.19.1 Company Overview
10.19.2 Financial Performance
10.19.3 Product Benchmarking
10.19.4 Strategic Initiatives
10.20 Kibow Biotech
10.20.1 Company Overview
10.20.2 Financial Performance
10.20.3 Product Benchmarking
10.20.4 Strategic Initiatives
10.21 Calpis Co., Ltd.
10.21.1 Company Overview
10.21.2 Financial Performance
10.21.3 Product Benchmarking
10.21.4 Strategic Initiatives
10.22 Osprey Biotechnics
10.22.1 Company Overview
10.22.2 Financial Performance
10.22.3 Product Benchmarking
10.22.4 Strategic Initiatives
10.23 Probiotic Australia PL
10.23.1 Company Overview
10.23.2 Financial Performance
10.23.3 Product Benchmarking
10.23.4 Strategic Initiatives
10.24 Protexin
10.24.1 Company Overview
10.24.2 Financial Performance
10.24.3 Product Benchmarking
10.24.4 Strategic Initiatives
10.25 UAS Laboratories
10.25.1 Company Overview
10.25.2 Financial Performance
10.25.3 Product Benchmarking
10.25.4 Strategic Initiatives
10.26 Qingdao Vland Biotech Group Co.
10.26.1 Company Overview
10.26.2 Financial Performance
10.26.3 Product Benchmarking
10.26.4 Strategic Initiatives
10.27 BJP Laboratories Pty. Ltd.
10.27.1 Company Overview
10.27.2 Financial Performance
10.27.3 Product Benchmarking
10.27.4 Strategic Initiatives
10.28 Cell Biotech International A/S
10.28.1 Company Overview
10.28.2 Financial Performance
10.28.3 Product Benchmarking
10.28.4 Strategic Initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Probiotical S.p.A.
  • Ganeden Inc.
  • Sabinsa Corporation
  • Biocodex, Inc.
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • Danisco A/S
  • Danone, Inc.
  • Lallemand, Inc.
  • Nebraska Cultures
  • Probi AB
  • Allianz Biosciences Pvt. Ltd.
  • Lactosan GmbH & Co. KG
  • Nutraceutix
  • Probium LLC
  • THT s.a.
  • Vitakem Nutraceutical, Inc.
  • ProbioFerm
  • Orbit Biotech Pvt. Ltd.
  • Kibow Biotech
  • Calpis Co., Ltd.
  • Osprey Biotechnics
  • Probiotic Australia PL
  • Protexin
  • UAS Laboratories
  • Qingdao Vland Biotech Group Co.
  • BJP Laboratories Pty. Ltd.
  • Cell Biotech International A/S
Note: Product cover images may vary from those shown
Adroll
adroll